Like Mango Health

announced 9/11/2019 via PR Newswire

TrialCard, will acquire Mango Health

synopsis: TrialCard, a company that provides patient affordability, medication access and adherence, and patient support services on behalf of pharmaceutical manufacturers, announced it will acquire Mango Health, the leading provider of mobile-based medication management and adherence solutions for the life sciences sector.
buyer parent: Odyssey Investment Partners
buyer: TrialCard
TrialCard Incorporated provides patient affordability, medication access and adherence, and patient support services on behalf of pharmaceutical manufacturers. TrialCard has connected over 30 million patients with nearly $12 billion in branded drug savings to date. "
target: Mango Health
Mango Health is the leading digital medication management platform. It provides a critical support tool to help patients manage medications, stay on track, and have fun in the process. For payers, the platform provides a crucial window into patients' daily lives and a platform for interventions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/14/2018 via BNC Analysis

Co-op, acquired DIMEC

synopsis: Co-op, the Manchester-based consumer co-operative group ,bought healthcare technology start-up Dimec which enables patients and their General Practitioner (GPs) to interact and manage prescriptions. DIMEC is the free and easy way of ordering prescriptions 24/7.
buyer: Co-op
Co-op is one of the world’s largest consumer co-operatives, owned by millions of members. Co-op is the UK’s sixth biggest food retailer with more than 2,500 local, convenience and medium-sized stores. Co-op is also the UK's number 1 funeral services provider, a major general insurer, and more. "
target: DIMEC
UK-based Healthcare technology platform Dimec has developed an app that enables patients and their General Practitioners (GPs) to interact and better manage their prescription needs. DIMEC is the free and easy way of ordering prescriptions 24/7.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/23/2017 via PR Newswire

Digital Pharmacist Inc., acquired PocketRx App

synopsis: Digital Pharmacist Inc., a rapidly growing digital health company, announced that it has acquired PocketRx, a mobile app that allows patients to manage their prescriptions. Over three hundred pharmacy brands including multi-store locations use the PocketRx app.
buyer: Digital Pharmacist Inc.
Digital Pharmacist Inc. is a rapidly growing digital health company that offers an omni-channel patient engagement platform for 6,000 pharmacies, national pharmacy wholesalers, hospital systems and pharmaceutical brands. Four million patients use the company's products every month. "
target parent: Praeses, LLC.
target: PocketRx App
PocketRx is a mobile app that allows patients to manage their prescriptions. Over three hundred pharmacy brands including multi-store locations such as Denver Health Pharmacy, USave Pharmacy and Owen's Healthcare use the PocketRx app.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/31/2016 via BNC Analysis

MedAdvisor Limited, acquired Healthnotes

synopsis: MedAdvisor has announced the acquisition of Healthnotes, a leader in healthcare technology for medication adherence management. Healthnotes' core platform promotes patient medication adherence, along with pharmacy loyalty by offering prescription management services to patients.
buyer: MedAdvisor Limited (ASX:MDR:$1.05)
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records. "
target: Healthnotes
Healthnotes is a privately held Melbourne based healthcare technology company with an innovative platform that manages patient messaging and medication adherence across multiple demographics.
price ($mm)
$4.19
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via GlobeNewswire

Tabula Rasa Healthcare, acquired Prescribe Wellness

synopsis: Tabula Rasa HealthCare, a healthcare technology company advancing the field of medication safety, announced that it has acquired PrescribeWellness, a leading cloud-based patient relationship management solutions company that facilitates collaboration between more than 10,000 pharmacies with patients, payers, providers and pharmaceutical companies.
buyer: Tabula Rasa Healthcare (TRHC:$204.27)
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize patient outcomes, lower healthcare costs and improve organizational performance. "
target: Prescribe Wellness
PrescribeWellness is a leading cloud-based patient relationship management solutions company that facilitates collaboration between more than 10,000 pharmacies with patients, payers, providers and pharmaceutical companies.
price ($mm)
$150
rev ($mm)
$29
EBITDA ($mm)
$0
EV / rev
5.2x
EV / EBITDA
500.0x
closed 4/28/2014 via BusinessWire

Accolade, Inc., acquired konciergeMD

synopsis: Accolade, an innovative consumer engagement company, has acquired konciergeMD, a cloud-based consumer engagement company, singularly focused on helping patients and their families work more closely with their care team to improve outcomes. The acquisition will enahnce Accolade's leading consumer healthcare engagement service.
buyer: Accolade, Inc.
Accolade uses their Accolade Health Assistants- a single point of contact for any health benefit or healthcare need, to improve people's healthcare experience while lowering costs for large employers, payers and Accountable Care Organizations. "
target: konciergeMD
konciergeMD is a first-of-its-kind, cloud-based consumer engagement company, singularly focused on helping patients and their families work more closely with their care team to improve outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/29/2016 via PR Newswire

Decision Resources Group, acquired Adaptive Software LLC

synopsis: Decision Resources Group (DRG) announced that it has acquired Adaptive Software. The company is a group of developers of market-leading pharmacy benefit and formulary management software platforms.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd., offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 900 employees across 15 offices in North America, Europe and Asia. "
target: Adaptive Software LLC
Adaptive Software, located in Kansas City, currently offers to health plans and Pharmacy Benefit Managers (PBMs) a suite of software solutions that streamlines formulary management, pharmacy networking, pricing, and pharmacy benefit design.
price ($mm)
$7.40
rev ($mm)
$3
EBITDA ($mm)
EV / rev
7.7x
EV / EBITDA
closed 10/15/2012 via GlobeNewswire

ExlService Holdings, Inc., acquired Landacorp, Inc.

synopsis: ExlService Holdings, Inc. announced it has acquired Landacorp Inc., significantly increasing its capabilities to serve the healthcare industry. Landacorp is a leading provider of healthcare solutions and technology with more than 50 million members under management on its platforms.
buyer: ExlService Holdings, Inc. (EXLS:$786.25)
ExlService Holdings, Inc. is a leading provider of outsourcing and transformation services. EXL primarily serves the needs of Global 1000 companies from global delivery centers in the insurance, healthcare, utilities, banking and financial services, transportation and logistics, and travel sectors. "
target parent: Welsh, Carson, Anderson & Stowe
target: Landacorp, Inc.
Landacorp's flagship CareRadius suite is a flexible platform designed to integrate a payer's internal and external data to streamline workflows, support collaboration among healthcare professionals and drive better health decision making with analytics.
price ($mm)
$38
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/25/2018 via BNC Analysis

cliexa, acquired Preventative Technology Solutions, Inc.

synopsis: cliexa, a provider of chronic care management products and services, has acquired Preventative Technology Solutions Inc (PTSI), a software development company that creates medical assessment apps and mhealth prevention services. PTSI's OPTIONS mobile app gathers sexual risk information from patients to produce a structured report for practitioners.
buyer: cliexa
cliexa is a provider of chronic care management products and services that enable patients to track their chronic disease activity with clinically-proven and scientifically-tested scoring models. cliexa provides specialized platforms for varying chronic care conditions to better suit each patient. "
target: Preventative Technology Solutions, Inc.
Preventative Technology Solutions is a software development company that creates medical assessment apps and mhealth prevention services to reduce risk behaviors in young adults. Their OPTIONS mobile app gathers sexual risk information from patients to produce a structured report for practitioners.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/29/2018 via PR Newswire

SensorRX, Inc., will acquire Welltodo, LLC

synopsis: SensorRX, Inc., a leading provider of patient generated health data (PGHD), has agreed to terms to acquire Welltodo, LLC, developer of the iPhone application Migraine Coach™. St. Louis-based Welltodo broke new ground in early 2015 with Migraine Coach, a migraine management application for consumers.
buyer: SensorRX, Inc.
Charlotte, North Carolina-based SensorRx provides a chronic disease management platform that uses the power of smartphones to improve patient outcomes. MigrnX, the company's first Patient Generated Health Data product, provides clinicians with accurate, actionable data for better treatment. "
target: Welltodo, LLC
Welltodo, LLC is the developer of the iPhone application Migraine Coach™, a migraine management application for consumers. Migraine Coach is a global leader with its iterative design principles and advanced algorithmic approach to tracking debilitating migraine headaches.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/13/2018 via BusinessWire

Fitbit Inc., will acquire Twine Health

synopsis: Fitbit, Inc., the leading global wearables brand, announced that it will acquire Twine Health, an innovative, proven health coaching platform that empowers people to achieve better health outcomes and helps health systems, health plans and workplace health providers lower healthcare costs.
buyer: Fitbit Inc. (FIT:$1,618.54)
Fitbit helps people lead healthier, more active lives by empowering them with data, inspiration and guidance to reach their goals. As the leader in the Connected Health & Fitness category, Fitbit designs products and experiences that track everyday health and fitness. "
target: Twine Health
Twine Health is an innovative, proven health coaching platform that empowers people to achieve better health outcomes and helps health systems, health plans and workplace health providers lower healthcare costs.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/13/2017 via PR Web

First Opinion, acquired Proxi

synopsis: First Opinion, Inc. announced it has acquired Incente, LLC, a behavioral health technology company based in Hanover, NH. In addition to the acquisition, First Opinion also announced the formation of a new business unit called Voi (http://voi.com).
buyer: First Opinion
First Opinion is a health technology company that offers tools for individuals and organizations. First Opinion App is an AI-assisted messenger that provides individuals access to care providers. Voi addresses vital behavioral health needs through advanced analytics and assessments. "
target: Proxi
Proxi, by Incente, is an app that provides easy access to and completion of behavioral health assessments. it enables online collaboration and connection between someone suffering with a behavioral health disorder and his/her family, friends, behavioral health coaches and clinicians.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/11/2017 via BNC Analysis

StayWell, acquired MedHelp

synopsis: StayWell, a health engagement company, has acquired MedHelp, the largest online health community and consumer health platform. MedHelp empowers 19 million users a month to better understand and better manage their health. They also provide mobile apps such as My Diet Diary, a calorie tracking app, and Sugar Sense, a top-ranked diabetes app.
buyer parent: Merck & Co., Inc.
buyer: StayWell
StayWell is a health engagement company that helps its clients engage and educate people to improve health and business results. StayWell brings decades of experience working across the health care industry to design solutions that address its clients’ evolving needs. "
target: MedHelp
MedHelp is the largest online health community and consumer health platform, empowering 19 million unique users a month to better understand and better manage their health. MedHelp also provides mobile apps such as My Diet Diary, a calorie tracking app, and Sugar Sense, a top-ranked diabetes app.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/26/2017 via PR Newswire

Health Wizz, acquired KreateIoT

synopsis: Health Wizz, a leading provider of wellness platform announced that it has acquired kreateIoT, the innovation leader in building blockchain applications for accessing healthcare records and data from wearables.
buyer: Health Wizz
Health Wizz is a mobile application with focus on both the individual user and the patient. Patients can use Health Wizz to securely track all of their healthcare data in one place. View data from wearable devices, medical records, and lab results, all in one place. "
target: KreateIoT
KreateIoT is the innovation leader in providing blockchain applications to address the interoperability challenges that the healthcare industry faces. They enable individuals to access and own their medical records, and control and direct the sharing of these records in a secure and private way.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/25/2014 via PR Newswire

Physicians Interactive, acquired MedHelp

synopsis: Physicians Interactive, a leading provider of online and mobile clinical resources and solutions for healthcare professionals, announced the acquisition of MedHelp, the online health community and health application site.
buyer parent: Merck & Co., Inc.
buyer: Physicians Interactive
Physicians Interactive is a provider of online and mobile clinical resources and solutions for healthcare professionals. PI uses the power of networks of healthcare professionals and life sciences companies together in ways that will change the practice and business of medicine for the better. "
target: MedHelp
MedHelp is the world's largest online health community and consumer health platform, empowering 14 million unique users a month to better understand and better manage their health.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/22/2013 via Market Wire

WellTok, Inc., acquired Incentone

synopsis: WellTok, the leading Social Health Management company, announced that it has acquired IncentOne, a pioneer in healthcare incentive design and management. The combined entity creates the industry's most robust Health Optimization Platform for entities that manage population health by matching consumers to activities designed to improve their health.
buyer: WellTok, Inc.
Welltok Inc. is a technology company focused on delivering web and mobile social media-based solutions to the U.S. health plan community. Their product, CafeWell, enables health plans to benefit from the power of social media while providing consumers with a health and wellness focused community. "
target parent: Camden Partners Holdings, LLC
target: Incentone
IncentOne is the leading provider of incentive solutions to the healthcare industry. This acquired expertise enables us to drive participation in lifestyle management programs, compliance with disease management programs, generic drug purchases and other health and wellness activities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/12/2018 via Company Press Release

Varian Medical Systems, Inc., acquired Noona Healthcare

synopsis: Varian, a leader in developing and delivering cancer care solutions, has announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based, mobile service designed to capture cancer patient-reported outcomes (PROs).
buyer: Varian Medical Systems, Inc. (VAR:$2,888.20)
Varian is a leader in developing and delivering cancer care solutions and is focused on creating a world without fear of cancer. Varian has pioneered developments in radiotherapy, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing. "
target: Noona Healthcare
Noona Healthcare is the developer of a cloud-based, mobile service designed to capture cancer patient-reported outcomes (PROs). The Noona patient software app lets clinics capture PROs and communicate directly with patients. They are based in Finland.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/18/2018 via BNC Analysis

First Foundry, acquired Aces Health

synopsis: Atlanta-based clinical trial platform Aces Health has been acquired by West Coast venture development firm, First Foundry. Aces, which was founded in 2014, automates patient engagement and data collection during clinical research trials. Aces is rebranding to Dedo, a word that means “data” in Greek.
buyer: First Foundry
First Foundry is part venture capital firm, research incubator, and software development agency. They often help high-potential startup companies in exchange for equity. Their portfolio largely consists of companies and projects in the gaming space, with a few companies in the healthcare vertical. "
target: Aces Health
Aces automates patient engagement and data collection during clinical research trials. The mobile platform connects to medical and tracking devices ranging from connected blood pressure cuffs to fitness wearables, collects all the patient data to deliver to researchers and providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/16/2017 via BNC Analysis

Verily Life Sciences, acquired Senosis Health Inc.

synopsis: Google's Verily unit has acquired Senosis Health. Senosis has developed a family of medical condition monitoring and measurement applications for use via smartphones.
buyer parent: Google Inc.
buyer: Verily Life Sciences
Verily lives at the intersection of technology, data science and healthcare. Verily is developing tools to collect and organize health data, then creating interventions and platforms that put insights derived from that health data to use for more holistic care management. "
target: Senosis Health Inc.
Senosis Health has developed a family of smartphone apps that monitor newborn jaundice, lung function and blood hemoglobin by using the smartphone’s camera and microphone.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/30/2017 via Company Press Release

Roche Ltd, acquired mySugr GmbH

synopsis: Roche and mySugr announced that the two partners have signed an agreement under which Roche acquired all shares of mySugr GmbH. Counting more than one million users globally, mySugr is one of the leading mobile diabetes platforms in the market.
buyer: Roche Ltd
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. "
target: mySugr GmbH
mySugr specializes in all-around care for people with diabetes. Its apps and services combine diabetes coaching, therapy management, unlimited test-strips, automated data tracking, and seamless integration with a growing number of medical devices to ease the daily burden of living with diabetes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/11/2019 via PR Newswire

TrialCard, will acquire Mango Health

synopsis: TrialCard, a company that provides patient affordability, medication access and adherence, and patient support services on behalf of pharmaceutical manufacturers, announced it will acquire Mango Health, the leading provider of mobile-based medication management and adherence solutions for the life sciences sector.
buyer parent: Odyssey Investment Partners
buyer: TrialCard
TrialCard Incorporated provides patient affordability, medication access and adherence, and patient support services on behalf of pharmaceutical manufacturers. TrialCard has connected over 30 million patients with nearly $12 billion in branded drug savings to date. "
target: Mango Health
Mango Health is the leading digital medication management platform. It provides a critical support tool to help patients manage medications, stay on track, and have fun in the process. For payers, the platform provides a crucial window into patients' daily lives and a platform for interventions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/11/2019 via PR Newswire

TrialCard, will acquire Mango Health

synopsis: TrialCard, a company that provides patient affordability, medication access and adherence, and patient support services on behalf of pharmaceutical manufacturers, announced it will acquire Mango Health, the leading provider of mobile-based medication management and adherence solutions for the life sciences sector.
buyer parent: Odyssey Investment Partners
buyer: TrialCard
TrialCard Incorporated provides patient affordability, medication access and adherence, and patient support services on behalf of pharmaceutical manufacturers. TrialCard has connected over 30 million patients with nearly $12 billion in branded drug savings to date. "
target: Mango Health
Mango Health is the leading digital medication management platform. It provides a critical support tool to help patients manage medications, stay on track, and have fun in the process. For payers, the platform provides a crucial window into patients' daily lives and a platform for interventions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/17/2019 via Company Press Release

TrialCard, acquired RxSolutions

synopsis: TrialCard, a company that offers customized patient access solutions exclusively for the pharmaceutical industry, has acquired RxSolutions, a privately-held company specializing in customized pharmaceutical reimbursement-based programs for both the marketing and clinical supply professional.
buyer parent: Odyssey Investment Partners
buyer: TrialCard
TrialCard offers customized patient access solutions exclusively for the pharmaceutical industry in support of product marketing, patient assistance programs, and phase IV clinical trials. TrialCard innovates by focusing on client brands and analyzing new trends in prescription optimization. "
target: RxSolutions
RxSolutions is a privately-held company with more than 20 years experience specializing in customized pharmaceutical reimbursement-based programs for both the marketing and clinical supply professional. They are known for their dedication to customer care at a remarkable value.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/21/2013 via BNC Analysis

DrugDev, acquired CFS Clinical

synopsis: DrugDev, an interactive network and data sharing platform for over 80,000 clinical trial doctors in 93 countries, announced its acquisition of CFS Clinical (CFS), the leading specialty provider focused on the business and financial management activities for clinical trials.
buyer: DrugDev
DrugDev helps the clinical trials industry run faster, cheaper and smarter trials. Experienced Investigators choose to be part of the free network to access new clinical trial opportunities they would not otherwise have learnt about. "
target: CFS Clinical
CFS Clinical (CFS) is a technology-enabled service provider focused on the business and financial management activities for clinical trials.CFS’ experts deliver best-in-class Investigator site payment and study startup solutions around the globe.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via PE Hub

Catalyst Clinical Research, LLC, acquired Tri Stat

synopsis: Catalyst Clinical Research, LLC, a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies, has acquired Triangle Biostatistics, LLC (Tri Stat), a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry.
buyer parent: NovaQuest
buyer: Catalyst Clinical Research, LLC
Catalyst Clinical Research is a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies. The company assists clients with their clinical development programs by providing therapeutically-aligned experts and teams and customized solutions. "
target: Tri Stat
Triangle Biostatistics (Tri Stat) is a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry. Tri Stat provides strong statistical consulting and programming support utilizing the latest computing technology.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/13/2016 via BusinessWire

Vitruvian Partners LLP, acquired Phlexglobal

synopsis: Phlexglobal, the thought leaders and specialists in the provision of electronic Trial Master File systems and services to the life sciences industry, announced an investment by Vitruvian Partners. The transaction establishes Vitruvian as majority shareholder of Phlexglobal, while previous majority investor Bridgepoint will exit the company.
buyer: Vitruvian Partners LLP
Vitruvian Partners is an independent European private equity firm that invests in high-growth Dynamic Situations. They focus on asset-light companies in targeted sectors with strong, sustainable growth, and in companies driven by new competitive advantage, a transition in business model, or events. "
target parent: Bridgepoint
target: Phlexglobal
Phlexglobal is a specialist provider of technology-enabled, Trial Master File (TMF & eTMF) document management solutions and other support services to the global clinical research market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/14/2014 via Company Press Release

Bridgepoint, acquired Phlexglobal

synopsis: Phlexglobal, the specialist provider of technology-enabled document management solutions and other support services to the global clinical research market, has been acquired by Bridgepoint Development Capital from Inflexion in a transaction totalling £42 million.
buyer: Bridgepoint
Bridgepoint is one of the most experienced private equity investment firms based in Europe. With a clear, long-term focus on sectors where it can invest in robust middle market companies, it typically acquires businesses valued between €200 million and €1 billion. "
target parent: Inflexion Private Equity Partners LLP
target: Phlexglobal
Phlexglobal is a specialist provider of technology-enabled, Trial Master File (TMF & eTMF) document management solutions and other support services to the global clinical research market.
price ($mm)
$72
rev ($mm)
$25
EBITDA ($mm)
$7
EV / rev
2.8x
EV / EBITDA
9.6x
announced 7/18/2012 via BusinessWire

Adjility Health will be merged with Alliance Life Sciences Consulting Group, Inc,

synopsis: Alliance Life Sciences Consulting Group (ALSCG), a leading management and technology consultancy, and Adjility Consulting, a consulting firm specializing in management consulting and analytic solutions for clinical operations and the global market access, pricing and reimbursement space, announced that the two companies will merge.
buyer: Alliance Life Sciences Consulting Group, Inc
Alliance Life Sciences Consulting Group employs more than 175 professionals who collectively understand the business challenges of the Life Sciences industry and offer solutions for Sales & Marketing, Managed Care & Government Contracting, Commercial Operations, Information Management and Analytics."
target: Adjility Health
Adjility Health is dedicated to helping healthcare companies improve their operations through the use of strategic consulting services and very industry domain-specific analytic, forecasting, predictive trending and other data insight tools.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/26/2012 via BusinessWire

Accenture, acquired Octagon Research Solutions, Inc.

synopsis: Accenture completed its acquisition of Octagon Research Solutions, a provider of clinical and regulatory information management solutions and software for the pharmaceutical industry. The acquisition enhances Accenture's existing clinical services capabilities – including clinical data management, clinical programming and safety case processing.
buyer: Accenture (ACN:$41,244.27)
Accenture is a global management consulting, technology services and outsourcing company. Accenture collaborates with clients to help them become high performance businesses and governments. "
target parent: Edison Ventures
target: Octagon Research Solutions, Inc.
Octagon Research Solutions is the world leader in clinical and regulatory information management solutions to the life sciences industry. Through an integrated suite of outsourced services, strategic consulting, and innovative technology, Octagon optimizes the entire drug development lifecycle.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/25/2017 via BusinessWire

Konica Minolta, Inc., will acquire Invicro, LLC

synopsis: Konica Minolta, Inc. and Boston-based Invicro LLC announced that they have concluded an agreement whereby Konica Minolta will acquire Invicro, a leading provider of imaging services and software for research and drug development.
buyer: Konica Minolta, Inc. (TSE:4902:$9,474.88)
Konica Minolta, Inc. is a Japanese technology company headquartered in Tokyo. The company manufactures business and industrial imaging products, including copiers, laser printers, multi-functional peripherals (MFPs) and digital print systems for the production printing market. "
target: Invicro, LLC
Invicro is a leading provider of imaging services and software for research and drug development. Headquartered in Boston, Massachusetts, Invicro LLC was founded in 2008 with the mission of improving the role and function of imaging in drug discovery and development across all therapeutic areas.
price ($mm)
rev ($mm)
$106
EBITDA ($mm)
$17
EV / rev
0.0x
EV / EBITDA
0.0x
closed 12/16/2016 via PR Newswire

Indegene Lifesystems Pvt Ltd., acquired Wincere, Inc.

synopsis: Indegene, a global healthcare solutions provider, announced the acquisition of Wincere Inc. Wincere is a leading clinical data management and clinical and statistical programming solutions provider located on the West Coast in Silicon Valley, CA. Wincere is deeply engaged with clinical R&D needs of many emerging biopharma companies.
buyer: Indegene Lifesystems Pvt Ltd.
Indegene enables global healthcare organizations to address complex challenges by seamlessly integrating analytics, technology, operations and medical expertise and drives better health and business outcomes. "
target: Wincere, Inc.
Wincere provides smarter clinical research services across all clinical trial phases by using its patent-pending technology to support clinical trial startup, conduct, and submission activities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/27/2018 via Company Press Release

The WIRB-Copernicus Group, acquired ACI Clinical

synopsis: WIRB-Copernicus Group, the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, has acquired ACI Clinical, a specialty provider of clinical trial committees and clinical trial advisory services.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions to measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: ACI Clinical
ACI Clinical is a specialty provider of clinical trial committees and clinical trial advisory services. ACI Clinical specializes in clinical and safety consulting, including full service Endpoint Adjudication Committees and Data Monitoring Committees.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/15/2014 via BNC Analysis

Synchrogenix Information Strategies, Inc. merged with Certara,

synopsis: Arsenal Capital Partners have acquired Synchrogenix Information Strategies Inc., which will merge with Certara LP. Synchrogenix, a specialty contract research organization providing strategic regulatory writing and related services to pharmaceutical, biotechnology, and medical device companies worldwide.
buyer parent: Arsenal Capital Partners
buyer: Certara
Certara™ is dedicated to improving human health through a broad spectrum of software products and services, from molecular discovery through clinical development, with special focus on supporting translational approaches to drug development. "
target: Synchrogenix Information Strategies, Inc.
Synchrogenix is a specialty contract research organization providing strategic regulatory writing and related services to pharmaceutical, biotechnology, and medical device companies worldwide. The company offers pre-clinical, clinical, CMC, and drug safety writing and submission services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/4/2013 via PR Newswire

Accelera Innovations, Inc., will acquire Behavioral Health Care Associates, Ltd.

synopsis: Accelera Innovations, Inc., a provider of cloud based software-as-a-service solutions to the healthcare industry announced that they have signed a stock purchase agreement to acquire 100% of Behavioral Health Care Associates, Ltd., a provider of billing, practice management and administrative services to doctors and other clinicians.
buyer: Accelera Innovations, Inc.
Accelera Innovations, Inc. offers cloud based software-as-a-service solutions to the healthcare industry that includes technology and services to providers and payers, who are seeking to create an interoperable technology platform that is patient-centric. "
target: Behavioral Health Care Associates, Ltd.
Behavioral Health Care Associates, Ltd. provides billing, practice management and administrative services to doctors and other clinicians who provide services to hospitals, nursing homes and individual clients.
price ($mm)
$4.55
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/20/2012 via PR Newswire

ePharmaSolutions, Inc., acquired Polaris Biopharma Consulting

synopsis: ePharmaSolutions announced the acquisition of Polaris BioPharma Consulting, a leading global patient recruitment and retention firm headquartered in Slough, UK. Polaris Biopharma was founded in 1999 as a boutique patient recruitment and retention firm supporting global pharmaceutical companies.
buyer: ePharmaSolutions, Inc.
ePharmaSolutions is a leading provider of technology-based clinical services that helps improve the way sites are selected, trained, activated and managed to exceed enrollment goals. ePharmaSolutions won the 2009 Bio-IT World Award for best clinical trial technology. "
target: Polaris Biopharma Consulting
Polaris Biopharma Consulting is a boutique patient recruitment and retention firm. Polaris has helped large and mid-sized pharmaceutical companies and CROs develop and deploy hundreds of global feasibility, trial optimisation and patient recruitment programs in every major therapeutic area.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/13/2006 via BusinessWire

Applied Clinical Intelligence merged with TAKE Solutions, Inc.,

synopsis: TAKE Solutions, Inc. announced the formation of the OneClinical brand of life sciences offerings as part of its merger with Applied Clinical Intelligence and OnSphere Corporation. OneClinical combines a full spectrum of proven data and document management software products and services for clinical trials, drug and device development lifecycles.
buyer parent: Shriram Group
buyer: TAKE Solutions, Inc. (BSE:532890:$259.76)
TAKE Solutions is a leading international business technology company with products backed by a strong domain expertise to provide cost-effective comprehensive solutions for businesses. "
target: Applied Clinical Intelligence
Applied Clinical Intelligence was founded in 2001 to provide data-driven solutions for clinical trials and risk management programs. ACI is a specialized clinical services group offering strategic, operational, and technical intelligence.
price ($mm)
$4.71
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/9/2017 via PR Newswire

The WIRB-Copernicus Group, acquired ProPhase, LLC

synopsis: WIRB-Copernicus Group® (WCG™), the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research, announced that it has acquired ProPhase. ProPhase is a global provider of measurement-related specialty solutions in clinical trials.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs, and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: ProPhase, LLC
ProPhase is a global provider of measurement-related specialty solutions in clinical trials. For over a decade, ProPhase has focused on applying innovation to optimize the selection, use, and analysis of behavioral endpoints to mitigate trial risk and maximize the likelihood of study success.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/1/2005 via Company Press Release

Thomson Pharma, acquired Pharmaceutical Information Associates, Ltd.

synopsis: The Thomson Corporation announced that it has acquired Pharmaceutical Information Associates Ltd (PIA) and Astrolabe Analytica, Inc. (AAI). PIA and AAI are leading providers of regulatory consulting, marketing analytics and scientific communications services for the pharmaceutical industry.
buyer parent: The Thomson Corporation
buyer: Thomson Pharma
Thomson Pharma is a dynamic, information offering for the pharmaceutical and biotechnology industries that is being developed by Thomson Scientific. "
target: Pharmaceutical Information Associates, Ltd.
Since 1990, Pharmaceutical Information Associates has supported the global drug development process by assisting with regulatory strategy development, the preparation of regulatory documentation, and the design, conduct, and audit of specialized clinical studies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via Company Press Release

Advarra, acquired Kinetiq

synopsis: Advarra, the premier provider of institutional review board (IRB) and research quality and compliance consulting services, acquired Quorum’s research and technology consulting division, Kinetiq. Kinetiq delivers innovative solutions for human subject protection and compliance in clinical research.
buyer parent: Linden Capital Partners
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target parent: Quorum Review IRB
target: Kinetiq
Kinetiq is a consulting and technology division of Quorum Review IRB that delivers innovative solutions for human subject protection and compliance in clinical research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/27/2013 via Company Press Release

PPD, Inc., acquired Acurian, Inc.

synopsis: Pharmaceutical Product Development, LLC, a leading global contract research organization providing drug discovery, development, lifecycle management and laboratory services, announced it has acquired Acurian, a leading full-service provider of clinical trial patient enrollment and retention solutions for the life sciences industry.
buyer: PPD, Inc.
PPD is a leading global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. PPD's clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. "
target: Acurian, Inc.
Acurian, Inc. provides solutions needed to recruit, enroll, and retain patients for clinical trials. It offers recruitment feasibility, site identification and selection, patient recruitment and retention, and cancer solutions; and formulates a plan based on historical performance data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/5/2006 via PR Newswire

Ventiv Health, acquired Synergos, Inc.

synopsis: inVentiv Health, Inc. announced the completion of its acquisitions of Synergos, Inc., a focused clinical services provider, and Jeffrey Simbrow Associates Inc., Canada's leading healthcare marketing and communications agency. Both acquisitions were announced by inVentiv on March 13.
buyer: Ventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Synergos, Inc.
Synergos, Inc. is a functional service provider specializing in clinical trials management services, particularly project management and monitoring as well as investigator and patient recruitment. Synergos also provides regulatory affairs and quality compliance services.
price ($mm)
$5.75
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/1/2014 via BusinessWire

Perficient, Inc., acquired BioPharm Systems, Inc.

synopsis: Perficient, Inc., a leading information technology consulting firm serving Global 2000 and other large enterprise customers throughout North America, announced it has acquired BioPharm Systems, Inc., a $15 million annual services revenue business and information technology consulting firm focused on the life sciences industry.
buyer: Perficient, Inc. (PRFT:$511.25)
Perficient is a leading information technology consulting firm serving Global 2000 and enterprise customers throughout North America. Perficient’s professionals serve clients from a network of offices across North America and three offshore locations, in Eastern Europe, India, and China. "
target: BioPharm Systems, Inc.
BioPharm Systems is a global IT consulting and managed services provider that focuses on the life sciences industry. BioPharm Systems has extensive experience in the implementation, integration, migration, upgrade, and hosting of clinical trial management, drug safety and pharmacovigilance and more.
price ($mm)
$18
rev ($mm)
$15
EBITDA ($mm)
EV / rev
1.2x
EV / EBITDA
closed 3/12/2014 via PR Web

d-Wise Technologies Inc., acquired Dootsonic Ltd.

synopsis: d-Wise Technologies, UK Ltd., announced that it has entered into an agreement to acquire Dootsonic Ltd., a privately-owned technology organization specializing in the support of the management, analysis and reporting of data from clinical trials.
buyer: d-Wise Technologies Inc.
d-Wise is a technology leader with the expertise to empower world-class life science and healthcare organizations to resolve their business optimization challenges, helping them rapidly harness and leverage data, systems and processes to gain competitive advantage. "
target: Dootsonic Ltd.
Dootsonic is a specialty technology consulting company, focused primarily on biometrics technology and process, providing high quality services for their clients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Mango Health


read more

Mango Health

DIMEC

PocketRx App

Healthnotes

Prescribe Wellness

konciergeMD

Adaptive Software LLC

Landacorp, Inc.

Preventative Technology Solutions, Inc.

Welltodo, LLC

Twine Health

Proxi

MedHelp

KreateIoT

MedHelp

Incentone

Noona Healthcare

Aces Health

Senosis Health Inc.

mySugr GmbH

read more

Mango Health

read more

Mango Health

RxSolutions

read more

CFS Clinical

Tri Stat

Phlexglobal

Phlexglobal

Adjility Health

Octagon Research Solutions, Inc.

Invicro, LLC

Wincere, Inc.

ACI Clinical

Synchrogenix Information Strategies, Inc.

Behavioral Health Care Associates, Ltd.

Polaris Biopharma Consulting

Applied Clinical Intelligence

ProPhase, LLC

Pharmaceutical Information Associates, Ltd.

Kinetiq

Acurian, Inc.

Synergos, Inc.

BioPharm Systems, Inc.

Dootsonic Ltd.

Geography
Matching Companies
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2016
rev ($mm)
$1.05
EBITDA ($mm)
($2.13)
EBIT ($mm)
($2.15)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.85)
EBIT ($mm)
($0.91)
Net Income ($mm)
Employees
7
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: INOV
 
 
 
 
 
 
 
 
Inovalon, Inc.
Inovalon, Inc.
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape.
year
2017
rev ($mm)
$449.36
EBITDA ($mm)
$75.91
EBIT ($mm)
$27.16
Net Income ($mm)
$34.82
Employees
2119
  • drill down
  • watch
Ticker: TSXV:MSD
 
 
 
 
 
 
 
 
Moseda Technologies, Inc.
Moseda Technologies, Inc.
Moseda Technologies is a software developer of secure mobile health and telemedicine solutions for the healthcare sector. Their SmartCare solution integrates the latest in mobile, wearables and SaaS technology to provide increased levels of efficiency and reduction in redundant administrative tasks.
year
2015
rev ($mm)
$0.02
EBITDA ($mm)
($1.86)
EBIT ($mm)
($1.86)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: DB:COP
 
 
 
 
 
 
 
 
CompuGroup Medical AG
CompuGroup Medical AG
CompuGroup Medical is a leading global eHealth provider. Their software and communications solutions assist doctors, dentists, hospitals, pharmacists, associations, networks and other service providers with workflow, diagnosis and therapy.
year
2018
rev ($mm)
$830.72
EBITDA ($mm)
$205.39
EBIT ($mm)
$158.54
Net Income ($mm)
$97.39
Employees
4572
  • drill down
  • watch
Ticker: AIM:EMIS
 
 
 
 
 
 
 
 
EMIS Group PLC
EMIS Group PLC
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems.
year
2018
rev ($mm)
$216.76
EBITDA ($mm)
$33.15
EBIT ($mm)
$21.39
Net Income ($mm)
$14.24
Employees
2046
  • drill down
  • watch
Ticker: EVH
 
 
 
 
 
 
 
 
Evolent Health
Evolent Health
Evolent partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent helps physicians and health systems achieve superior quality and cost results.
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
  • drill down
  • watch
Ticker: MTBC
 
 
 
 
 
 
 
 
Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp.
MTBC (Medical Transcription Billing, Corp) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers, revenue cycle management companies and software vendors.
year
2016
rev ($mm)
$21.30
EBITDA ($mm)
($1.14)
EBIT ($mm)
($5.80)
Net Income ($mm)
Employees
1600
  • drill down
  • watch
Ticker: TSXV:BIO
 
 
 
 
 
 
 
 
AioCare
AioCare
AioCare, formerly known as Biosign Technologies, develops and sells cloud-based healthcare software products that address the needs in clinic management, home care operations, health monitoring and virtual care management. Their cutting edge technology is transforming Healthcare delivery in Germany.
year
2015
rev ($mm)
$0.38
EBITDA ($mm)
($3.04)
EBIT ($mm)
($3.43)
Net Income ($mm)
$1.21
Employees
16
  • drill down
  • watch
Ticker: MDSO
 
 
 
 
 
 
 
 
Medidata Solutions Worldwide
Medidata Solutions Worldwide
Medidata Solutions is a leading global provider of cloud-based clinical development solutions that enhance the efficiency of customers’ clinical trials. Medidata’s advanced platform lowers the total cost of clinical development by optimizing clinical trials from concept to conclusion.
year
2019
rev ($mm)
$660.00
EBITDA ($mm)
$80.64
EBIT ($mm)
$42.88
Net Income ($mm)
$52.74
Employees
1998
  • drill down
  • watch
Ticker: OTCPK:OMCM
 
 
 
 
 
 
 
 
OmniComm Systems, Inc.
OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments.
year
2019
rev ($mm)
$24.62
EBITDA ($mm)
$1.80
EBIT ($mm)
$1.31
Net Income ($mm)
$1.83
Employees
175
  • drill down
  • watch
Ticker: OTCPK:SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc
Scrypt builds secure cloud-based workflow management and collaboration tools for regulated industries. They help businesses operating in regulated industries improve document workflow and regain valuable time while protecting business-critical information.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.86)
EBIT ($mm)
($0.92)
Net Income ($mm)
Employees
7
  • drill down
  • watch
Ticker: BSE:532890
 
 
 
 
 
 
 
 
TAKE Solutions, Inc.
TAKE Solutions, Inc.
TAKE Solutions delivers domain-intensive services in Life Sciences and Supply Chain Management. Their range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry networks forums.
year
2018
rev ($mm)
$259.76
EBITDA ($mm)
$39.17
EBIT ($mm)
$33.43
Net Income ($mm)
$28.24
Employees
1500
  • drill down
  • watch
Ticker: WX
 
 
 
 
 
 
 
 
WuXi AppTec
WuXi AppTec
WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in China and the United States. WuXi AppTec provides a broad and integrated portfolio of services throughout the drug R&D process.
year
2014
rev ($mm)
$640.80
EBITDA ($mm)
$155.57
EBIT ($mm)
$108.53
Net Income ($mm)
$112.01
Employees
7445
  • drill down
  • watch
Ticker: AIM:C4XD
 
 
 
 
 
 
 
 
C4X Discovery
C4X Discovery aims to become the world’s most productive drug discovery and development company by exploiting cutting-edge technologies to design and create best-in-class drug candidates.
year
2015
rev ($mm)
$0.44
EBITDA ($mm)
($5.46)
EBIT ($mm)
($5.50)
Net Income ($mm)
Employees
19
  • drill down
  • watch
Ticker: XTRA:EVT
 
 
 
 
 
 
 
 
Evotec BioSystems GmbH
Founded in Hamburg Germany, Evotec BioSystems GmbH is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists.
year
2017
rev ($mm)
$226.46
EBITDA ($mm)
$53.38
EBIT ($mm)
$38.55
Net Income ($mm)
$40.69
Employees
1316
  • drill down
  • watch
Ticker: SYNH
 
 
 
 
 
 
 
 
INC Research, Inc.
INC Research, Inc.
INC Research is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries.
year
2018
rev ($mm)
$3,472.40
EBITDA ($mm)
$441.82
EBIT ($mm)
$157.52
Net Income ($mm)
Employees
21000
  • drill down
  • watch
Ticker: ICLR
 
 
 
 
 
 
 
 
ICON Plc
ICON Plc
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development.
year
2015
rev ($mm)
$1,541.91
EBITDA ($mm)
$289.74
EBIT ($mm)
$234.82
Net Income ($mm)
$192.14
Employees
11200
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
CMIC Co., Ltd.
CMIC is a leading full-service CRO in Japan offering a wide range of services in clinical trials in Asia to both multi-national and Japanese pharma companies.
year
2019
rev ($mm)
$664.65
EBITDA ($mm)
$76.21
EBIT ($mm)
$43.15
Net Income ($mm)
$23.12
Employees
4962
  • drill down
  • watch
Ticker: PIELF
 
 
 
 
 
 
 
 
Pierrel SpA
Pierrel SpA
Pierrel S.p.A. is a pharmaceutical company specializing in contract research, development and the manufacture of medicines. The Pierrel Group boasts over 50 years of experience in the pharmaceutical sector, and is one of the main Italian manufacturers of local anaesthetics for dental use.
year
2008
rev ($mm)
$64.38
EBITDA ($mm)
($4.23)
EBIT ($mm)
($8.92)
Net Income ($mm)
Employees
504
  • drill down
  • watch
Ticker: ENCO
 
 
 
 
 
 
 
 
Encorium Group Inc.
Encorium is a full-service Contract Research Organization providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies. At Encorium we recognize the challenges that often arise during drug development.
year
2008
rev ($mm)
$35.91
EBITDA ($mm)
($5.19)
EBIT ($mm)
($6.89)
Net Income ($mm)
Employees
226
  • drill down
  • watch
Ticker: MCK
 
 
 
 
 
 
 
 
McKesson Corporation
McKesson Corporation
McKesson Corporation is a healthcare services and information technology company dedicated to making the business of healthcare run better. McKesson partners with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care.
year
2019
rev ($mm)
$214,319.00
EBITDA ($mm)
$4,229.00
EBIT ($mm)
$3,280.00
Net Income ($mm)
$34.00
Employees
70000
  • drill down
  • watch
Ticker: ENXTPA:ERF
 
 
 
 
 
 
 
 
Eurofins Group
Eurofins Group
Based in Luxembourg, Eurofins is a leading international group of laboratories providing a unique range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments.
year
2017
rev ($mm)
$3,467.64
EBITDA ($mm)
$637.81
EBIT ($mm)
$406.82
Net Income ($mm)
$252.97
Employees
34651
  • drill down
  • watch
Ticker: CRL
 
 
 
 
 
 
 
 
Charles River Laboratories International Inc.
Charles River Laboratories International Inc.
Charles River has been helping our global partners accelerate drug discovery and development by providing them with tailored research models and preclinical, clinical, support services.
year
2009
rev ($mm)
$1,202.55
EBITDA ($mm)
$282.48
EBIT ($mm)
$188.93
Net Income ($mm)
$114.44
Employees
8000
  • drill down
  • watch